“multiple-myeloma” Archives

in
Entry Author Date Location
In a Myeloma Setback, Merck Halts Studies Due to Patient Deaths 06/12/17 New York
Dragonfly, Tyler Jacks’s Disney-Backed Startup, Gets $33M in Celgene Deal 06/12/17 Boston
Keeping Focus on Cancer, Karyopharm Licenses Antiviral to Anivive 05/04/17 Boston
AACR Review: Biden Fired Up, Incyte Doubles Up, BMS Up And Down 04/06/17 National
Possible Cures. Mystery Deaths. Daunting Costs. Can CAR-T Be Tamed? 03/13/17 National
WARF, Cellectar Expand Licensing Agreement For Blood Cancer Drug 03/10/17 Wisconsin
After Navigating Ups and Downs, Cellectar CEO Caruso Looks to Future 02/21/17 Wisconsin
Lynx Bio Makes Headway on New Diagnostic for Blood Cancer Drugs 02/13/17 Wisconsin
Cellectar Awarded Another Cancer Drug Patent 01/26/17 Wisconsin
Exact Sciences, Fiserv, OneEvent, & More: This Week’s WI Watchlist 12/16/16 Wisconsin
At Late-Night ASH Talk, Juno Execs Look Beyond Stalled “Rocket” Trial 12/06/16 Seattle
ASH Roundup: CAR-T Shuffle, Hemophilia Updates, Checkpoint Progress & More 12/06/16 National
The Xconomy Immuno-Oncology Resource: A Mid-ASH T Cell Update 12/05/16 National
Bio Roundup: CAR-T Ups & Downs, Lilly’s Failure, Myeloma & More 12/02/16 National
In Year of CAR-T Trouble, Can Bluebird, Penn Make Headway in Myeloma? 11/30/16 Boston
Texas Roundup: UH Food Tech, Orb Health, NASA, CPRIT Grants, & More 11/30/16 Texas
Arrowhead, Microbes, Diabetes, & More: This Week’s WI Watchlist 11/18/16 Wisconsin
Cellectar Advances Drug Research With Pierre Fabre, Other Partners 11/18/16 Wisconsin
Bellicum, Molecular Templates Granted $32M for Immuno-Oncology Work 11/17/16 Texas
Silatronix, Propeller, BrainXell, & More: This Week’s WI Watchlist 11/08/16 Wisconsin
All In One Place: A New Immuno-Oncology Trial Resource 10/19/16 National
Epic, Astronautics, Virent, & More: This Week’s Wisconsin Watchlist 09/19/16 Wisconsin
UW-Madison Awarded $12M NCI Grant to Study Cellectar Cancer Drug 09/14/16 Wisconsin
Duchenne Lessons: Advocates For Rare Spinal Disease Have Eyes on FDA 08/26/16 National
Celgene Passes on Acetylon as Another Option-to-Buy Deal Flames Out 08/08/16 Boston
National Cancer Institute Awards Cellectar $2M For Clinical Study 08/05/16 Wisconsin
Agios, Celgene Jump into Immuno-Oncology in Revamped Alliance 05/17/16 Boston
Restructuring Looms for Forum as Neuro Drug Fails Key Clinical Test 03/24/16 Boston
Phoenix, Baird’s New CEO, & Epic’s Growth: This Week’s WI Watchlist 01/08/16 Wisconsin
East Coast Biotech Roundup: ASH, Kallyope, SQZ, Kyras & More 12/11/15 Boston
Page 1 of 3 next page »